BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33469265)

  • 1. Capsaicin Inhibits Proliferation and Induces Apoptosis in Breast Cancer by Down-Regulating FBI-1-Mediated NF-κB Pathway.
    Chen M; Xiao C; Jiang W; Yang W; Qin Q; Tan Q; Lian B; Liang Z; Wei C
    Drug Des Devel Ther; 2021; 15():125-140. PubMed ID: 33469265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of FBI-1 silencing on proliferation and apoptosis of triple-negative breast cancer cell line MDA-MB-231].
    Chen MJ; Wang L; Yang WP; Qin QH; Tan QX; Lian B; Wei CY
    Sheng Li Xue Bao; 2018 Oct; 70(5):497-503. PubMed ID: 30377688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
    Yan W; Ma X; Zhao X; Zhang S
    Drug Des Devel Ther; 2018; 12():3961-3972. PubMed ID: 30510404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
    Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
    Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
    Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
    Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.
    Mandal A; Bhatia D; Bishayee A
    Mol Carcinog; 2014 Dec; 53(12):999-1010. PubMed ID: 23846978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroxylon swietenia (Roxb.) DC induces cell death and apoptosis by down-regulating the NF-κB pathway in MCF-7 breast cancer cells: In vitro and in vivo investigations.
    Kamble SS; Choudhari J; Nimma R; Kumar TVS; Patil KK; Hese SV; Dawane BS; Gacche RN
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1600. PubMed ID: 35274824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
    Chang LC; Lin HY; Tsai MT; Chou RH; Lee FY; Teng CM; Hsieh MT; Hung HY; Huang LJ; Yu YL; Kuo SC
    Br J Pharmacol; 2014 Sep; 171(17):4010-25. PubMed ID: 24697523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
    Li T; Zhang Q; Zhang J; Yang G; Shao Z; Luo J; Fan M; Ni C; Wu Z; Hu X
    BMC Cancer; 2014 Feb; 14():96. PubMed ID: 24529079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL; Guo L; Wang GH
    Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of NGAL is Required for the Inhibition of Proliferation and the Promotion of Apoptosis of Human Gastric Cancer MGC-803 Cells.
    Han MY; Nie JW; Li YY; Zhu YZ; Wu G
    Cell Physiol Biochem; 2018; 50(2):694-705. PubMed ID: 30308516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).
    Kollipara PS; Jeong HS; Han SB; Hong JT
    Br J Pharmacol; 2013 Mar; 168(6):1471-84. PubMed ID: 23082969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
    Kang HJ; Lee SH; Price JE; Kim LS
    Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baohuoside I Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Apoptosis Signaling and NF-kB Pathway.
    Sun Y; Pang B; Wang Y; Xiao J; Jiang D
    Chem Biodivers; 2021 Jun; 18(6):e2100063. PubMed ID: 33904248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.